71 related articles for article (PubMed ID: 6671715)
1. Natural killer cell activity in patients with cervical cancer.
Seth P
Indian J Med Res; 1983 Nov; 78():689-93. PubMed ID: 6671715
[No Abstract] [Full Text] [Related]
2. Uterine cervical dysplasia & herpes simplex virus.
Luthra UK; Kotwani BG; Kochhar M; Khurana B; Seth P; Mohapatra LN; Mitra AB; Bhatnagar P; Prabhakar AK; Agarwal SS
Indian J Med Res; 1983 Jul; 78 Suppl():60-6. PubMed ID: 6654432
[No Abstract] [Full Text] [Related]
3. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
[No Abstract] [Full Text] [Related]
4. Influence of neoadjuvant polychemotherapy on natural killer cell activity in patients with locally advanced cervical squamous carcinoma.
Garzetti GG; Ciavattini A; Provinciali M; Valensise H; Romanini C; Fabris N
Gynecol Oncol; 1994 Jan; 52(1):39-43. PubMed ID: 7508412
[TBL] [Abstract][Full Text] [Related]
5. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
[TBL] [Abstract][Full Text] [Related]
6. [K- and NK-cells and their modification during therapeutic measures].
Wolf G; Rink B; Banaschak A
Radiobiol Radiother (Berl); 1984; 25(1):93-8. PubMed ID: 6729090
[No Abstract] [Full Text] [Related]
7. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma.
Mocchegiani E; Ciavattini A; Santarelli L; Tibaldi A; Muzzioli M; Bonazzi P; Giacconi R; Fabris N; Garzetti GG
Br J Cancer; 1999 Jan; 79(2):244-50. PubMed ID: 9888464
[TBL] [Abstract][Full Text] [Related]
8. Impaired natural killer cytotoxicity during recrudescence of recurrent herpes simplex virus type 1 infection.
Kuo YC; Lin CY; Cheng SF; Lin CC; Liu WT
Cancer Detect Prev Suppl; 1987; 1():51-5. PubMed ID: 3480065
[TBL] [Abstract][Full Text] [Related]
9. Sero-epidemiology of herpes type-2 virus and carcinoma of the cervix in Ibadan.
Adelusi B; Osunkoya BO; Fabiyi A
Afr J Med Med Sci; 1977 Jun; 6(2):95-102. PubMed ID: 416672
[TBL] [Abstract][Full Text] [Related]
10. Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ.
Aurelian L; Royston I; Davis HJ
J Natl Cancer Inst; 1970 Sep; 45(3):455-64. PubMed ID: 4331639
[No Abstract] [Full Text] [Related]
11. Natural cytotoxicity and serum blocking in malignant cervical neoplasia.
Pillai MR; Balaram P; Abraham T; Padmanabhan TK; Nair MK
Am J Reprod Immunol Microbiol; 1988 Apr; 16(4):159-62. PubMed ID: 3421407
[TBL] [Abstract][Full Text] [Related]
12. Influence of naproxen therapy on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus.
Gonik B; Loo LS; Bigelow R; Kohl S
J Reprod Med; 1984 Oct; 29(10):722-6. PubMed ID: 6512781
[TBL] [Abstract][Full Text] [Related]
13. Natural killer lymphocyte function in cervical cancer patients.
Pulay TA; Benczur M; Varga M
Neoplasma; 1982; 29(2):237-40. PubMed ID: 7110449
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix.
Vaquer S; Jordá J; López de la Osa E; Alvarez de los Heros J; López-García N; Alvarez de Mon M
Gynecol Oncol; 1990 Jan; 36(1):90-2. PubMed ID: 2295458
[TBL] [Abstract][Full Text] [Related]
15. Autologous herpes simplex virus-infected cells are lysed by human natural killer cells.
Yasukawa M; Zarling JM
J Immunol; 1983 Oct; 131(4):2011-6. PubMed ID: 6311903
[No Abstract] [Full Text] [Related]
16. Increased natural killer cell activity in uterine cervix cancer patients undergoing radiation therapy.
Pinel MI; Esteves EB; Rumjanek VM
Nat Immun; 1995 Apr; 14(4):216-24. PubMed ID: 8696011
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of immune responses of pelvic lymph node lymphocytes in patients with cervical cancer by sizofiran.
Shimizu Y; Chen JT; Hirai Y; Nakayama K; Hamada T; Fujimoto I; Hasumi K; Masubuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):2013-4. PubMed ID: 2531784
[No Abstract] [Full Text] [Related]
18. Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up.
Garzetti GG; Ciavattini A; Muzzioli M; Goteri G; Mannello B; Romanini C; Fabris N
Gynecol Obstet Invest; 1995; 40(2):133-8. PubMed ID: 8575692
[TBL] [Abstract][Full Text] [Related]
19. [Regulation of cytotoxic activities of natural killer cells in nasopharyngeal carcinoma: relations to serum interferon concentrations].
Mu M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1991; 26(1):32-5, 63. PubMed ID: 2031731
[TBL] [Abstract][Full Text] [Related]
20. Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
Cauda R; Citterio F; Tamburrini E; Pozzetto U; Tumbarello M; Castagneto M; Ortona L
Transplant Proc; 1988 Apr; 20(2 Suppl 2):186-9. PubMed ID: 2834839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
